The Intravascular Ultrasound Systems Market is estimated to be valued at USD 893.7 million in 2025 and is projected to reach USD 1455.7 million by 2035, registering a compound annual growth rate (CAGR) of 5.0% over the forecast period.
| Metric | Value |
|---|---|
| Intravascular Ultrasound Systems Market Estimated Value in (2025 E) | USD 893.7 million |
| Intravascular Ultrasound Systems Market Forecast Value in (2035 F) | USD 1455.7 million |
| Forecast CAGR (2025 to 2035) | 5.0% |
The intravascular ultrasound systems market is witnessing strong growth, driven by the increasing adoption of advanced imaging modalities for cardiovascular diagnosis and intervention. Rising incidences of coronary artery disease and peripheral vascular disorders are creating sustained demand for imaging technologies that provide precise visualization of vessel morphology. Intravascular ultrasound systems are being increasingly preferred because of their ability to deliver real-time cross-sectional imaging that supports accurate assessment of plaque burden, vessel size, and lesion characterization, enabling more effective treatment planning.
Advances in catheter miniaturization, imaging resolution, and integration with interventional tools are improving procedural outcomes while reducing procedural risks. Hospitals and specialty clinics are investing in these systems to enhance interventional cardiology capabilities and align with guidelines that recommend intravascular imaging in complex cases.
Growing awareness among clinicians about the clinical and economic benefits of improved diagnostic accuracy is further boosting adoption With global healthcare systems placing greater emphasis on early diagnosis and minimally invasive interventions, the market is positioned to expand steadily, supported by innovation in device design and broader clinical adoption across developed and emerging economies.
The intravascular ultrasound systems market is segmented by product type, application type, end user, and geographic regions. By product type, intravascular ultrasound systems market is divided into IVUS catheters, Mechanical/Rotatory Catheters, Static Electric/ Phased Array Catheters, IVUS consoles, Integrated Consoles, Cart version Consoles, Accessories, Pullback devices, Guide wires, and Introducer Sheaths. In terms of application type, intravascular ultrasound systems market is classified into IVUS coronary intervention market, IVUS coronary diagnostic market, IVUS coronary research market, and IVUS non-coronary /peripheral applications market. Based on end user, intravascular ultrasound systems market is segmented into Hospitals and Cancer Institute. Regionally, the intravascular ultrasound systems industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The IVUS catheters segment is projected to hold 21.6% of the intravascular ultrasound systems market revenue share in 2025, making it a leading product type. This dominance is being reinforced by the essential role of catheters in delivering intravascular imaging during coronary and peripheral interventions. The ability of IVUS catheters to provide high-resolution imaging of arterial walls supports precise diagnosis of stenosis severity and optimal stent deployment.
Demand for catheters is also being supported by the growing number of percutaneous coronary interventions, where real-time vessel assessment is critical for clinical success. Advances in catheter design, including improved flexibility, smaller diameters, and enhanced imaging transducers, are enabling physicians to navigate complex anatomies with greater ease and accuracy.
Increasing use of catheters in combination with other interventional tools is also broadening their application in both routine and complex procedures As hospitals and healthcare providers prioritize tools that improve patient outcomes and procedural efficiency, IVUS catheters are expected to maintain their significant share within the product portfolio of intravascular ultrasound systems.
The IVUS coronary intervention segment is expected to represent 41.2% of the intravascular ultrasound systems market revenue share in 2025, positioning it as the largest application segment. Its leadership is being driven by the rising prevalence of coronary artery disease and the growing reliance on intravascular imaging to optimize stent placement and guide interventional strategies. The ability of IVUS to accurately assess vessel dimensions, lesion composition, and stent expansion has reinforced its role as a standard of care in complex coronary procedures.
Clinical guidelines in several regions are recommending the use of intravascular imaging in high-risk patients, further stimulating adoption. The segment’s growth is also being supported by the increasing use of drug-eluting stents and advanced percutaneous coronary interventions, where precise imaging is critical for long-term patient outcomes.
Technological advancements in catheter-based ultrasound imaging, combined with growing operator awareness of the benefits of IVUS-guided procedures, are ensuring continued demand As cardiovascular disease burden increases globally, the IVUS coronary intervention segment is expected to sustain its position as the most significant application area.
The hospitals segment is anticipated to account for 58.6% of the intravascular ultrasound systems market revenue share in 2025, making it the leading end user. This dominance is being supported by the high volume of cardiovascular diagnostic and interventional procedures performed in hospital settings. Hospitals are increasingly adopting intravascular ultrasound systems to improve accuracy in diagnosing vascular conditions, support advanced interventional cardiology procedures, and align with evolving treatment guidelines.
The availability of skilled healthcare professionals, combined with access to advanced imaging infrastructure, has further reinforced hospital leadership in this market. Rising investments in healthcare infrastructure and the growing need to manage complex cardiovascular cases are also contributing to higher adoption in this setting.
Hospitals benefit from the ability to integrate IVUS systems with other imaging and interventional technologies, creating comprehensive diagnostic and treatment workflows As patient inflow for cardiovascular conditions continues to rise and hospitals seek to enhance procedural success rates while reducing complications, their reliance on intravascular ultrasound systems is expected to remain strong, consolidating their position as the dominant end-use category.
The Intravascular Ultrasound is designed with two major components i.e.
The imagining is captured by the frequency of the ultrasound which varies type of vessels which is to be scanned.
Two types of catheter systems are, one with an end-hole which are delivered over the guide wire, and those which do not have an end-hole and are introduced directly through the sheath.
The transducer design have been approached into two basic ways, i.e.
In the phased-array systems, there are multiple transducer elements (32-64) which are in arranged in an array are activated sequentially to generate the image.
Mechanical probes rotates an electric transducer at 1800 rpm, which has the capacity to produce 30 images per second.
There is drastic Increase in the number percutaneous coronary interventions and number of stent procedures. Major Lot of population now a days prefer less invasive procedures, the technological advancements in image guided therapeutic treatment and growing incidence of cardiovascular disease led to the increase in the intravascular ultrasound systems market.
The drawback for the IVUS is the high cost, lack of uniform reimbursement and threat from optical coherence tomography.
The global Intravascular Ultrasound Systems market is expected to expand at healthy CAGR owing to increasing adoption of the products across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and low cost.
Geographically, the global intravenous ultrasound systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for intravenous ultrasound systems due to high purchasing power.
Asia- Pacific is expected to account for second largest share in global market primarily due to increasing number of cardiac surgeries. Regional overview can be a directly proportional to the population.
Key players operating in the global intravenous ultrasound systems market are Volcano Corporation, Boston Scientific Corporation, Terumo Corporation, Infra ReDx Inc, Philips Healthcare, Siemens Healthcare, Silicon Valley Medical Instruments Inc, and Avinger Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
| Country | CAGR |
|---|---|
| China | 6.8% |
| India | 6.3% |
| Germany | 5.8% |
| France | 5.3% |
| UK | 4.8% |
| USA | 4.3% |
| Brazil | 3.8% |
The Intravascular Ultrasound Systems Market is expected to register a CAGR of 5.0% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.8%, followed by India at 6.3%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.8%, yet still underscores a broadly positive trajectory for the global Intravascular Ultrasound Systems Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.8%. The USA Intravascular Ultrasound Systems Market is estimated to be valued at USD 304.7 million in 2025 and is anticipated to reach a valuation of USD 462.1 million by 2035. Sales are projected to rise at a CAGR of 4.3% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 41.4 million and USD 31.0 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 893.7 Million |
| Product Type | IVUS catheters, Mechanical/Rotatory Catheters, Static Electric/ Phased Array Catheters, IVUS consoles, Integrated Consoles, Cart version Consoles, Accessories, Pullback devices, Guide wires, and Introducer Sheaths |
| Application Type | IVUS coronary intervention market, IVUS coronary diagnostic market, IVUS coronary research market, and IVUS non-coronary /peripheral applications market |
| End User | Hospitals and Cancer Institute |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Boston Scientific Corporation, Philips Healthcare, Siemens Healthineers, GE Healthcare, Canon Medical Systems Corporation, Terumo Corporation, Conavi Medical Inc., Infraredx, Inc., ACIST Medical Systems, Abbott Laboratories, Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Fujifilm Holdings Corporation, Hitachi, Ltd., Medtronic plc, Volcano Corporation, Bay Labs, Inc., CardioFlow Medtech, OpSens Medical, and Teleflex Incorporated |
The global intravascular ultrasound systems market is estimated to be valued at USD 893.7 million in 2025.
The market size for the intravascular ultrasound systems market is projected to reach USD 1,455.7 million by 2035.
The intravascular ultrasound systems market is expected to grow at a 5.0% CAGR between 2025 and 2035.
The key product types in intravascular ultrasound systems market are ivus catheters, mechanical/rotatory catheters, static electric/ phased array catheters, ivus consoles, integrated consoles, cart version consoles, accessories, pullback devices, guide wires and introducer sheaths.
In terms of application type, ivus coronary intervention market segment to command 41.2% share in the intravascular ultrasound systems market in 2025.
Explore Similar Insights
Intravascular Ultrasound Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
